Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation

Table 1

Patients’ characteristics.

						Baseline				Week 24
Pt	Age	Sex	Ethnic Grup^a	CDC	NPS Test^b	CD4+ cell/μL	HIV-RNA plasma log10 cp/mL	HIV-RNA CSF log10 cp/mL	CSF WBC cell/μL	CD4+ cell/μL	HIV-RNA plasma log10 cp/mL	HIV-RNA CSF log10 cp/mL	CSF WBC cell/μL
1	40	M	C	C3	+	100	4.04	5.40	20	176	1.59	2.6	0
2	47	M	I	C3	+^b	93	4.75	4.80	0	190	1.74	2.05	8
3	43	M	C	C3	+^b	32	2.67	3.45	12	186	2.49	2.08	15
4	49	F	C	C3	+^b	83	5.68	3.36	1	211	2.54
5	59	M	C	C3	+	102	5.75	4.14	1	317	2.46
6	27	M	I	C3	+	26	5.54	1.81	0	116	2.17	1.59	0
7	41	M	C	C3	−	42	5.87	3.26	0	234	1.76	1.59	0
8	36	M	C	B3	−	26	5.62	2.62	1	49	1.59	1.59	1
9	25	M	A	C3	−	172	5.16	4.16	0	145	1.59	1.59	0
10	25	F	I	B3	−	106	4.18	3.69	8	474	1.59	1.83	1
11	37	M	C	C3	−	148	5.36	2.63	0	448	2.27	2.16	0
12	53	M	C	C3	−	43	5.23	2.78	0	116	1.59	1.59	11

^a: C: Caucasian, A: African, and I: Ispanic.
^b: MND, +: altered NPS test.